Key Insights

Highlights

Treatment Research

2 treatments under study, led by All Patients

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown2

Clinical Trials (2)

Research Network

Common Treatments

  • All Patients1
  • Dual Energy Spectral Portal Venous Chest Computed Tomography1

Active Sponsors

  • Centre Chirurgical Marie Lannelongue1
  • Copenhagen University Hospital at Herlev1

Top Investigators

Related Conditions

  • Cardiac Failure1
  • Perioperativepostoperative Complications1
  • Pulmonary Embolusemboli1
  • Pulmonary Hypertension1
  • Venous Hypertension1

Activity Timeline